Abstract: A two-dimensional photonic crystal laser includes: electrodes; an active layer; and a two-dimensional photonic crystal layer in which modified refractive index regions are disposed to be shifted by different shift amounts from respective lattice points or/and are disposed at the respective lattice points with different areas, the shift amount or/and the area is/are modified with a composite modulation period and expressed by a modulation phase ?(r?) expressed using a vector r? indicating a position of each lattice point of the two-dimensional lattice, a vector kn? indicating a combination of an inclination angle and an azimuthal angle of each of n laser beams mutually differing in the inclination angle and/or the azimuthal angle, and an amplitude An and a phase exp(i?n) determined for each n and the amplitude An and/or the phase exp(i?n) for each value of n differ(s) from each other in at least two different values of n.

Abstract: To enhance a sound image localization effect and to ensure a good viewing state in which an image or video and audio have a sense of unity. Provided is a display in which an image is displayed in a display surface, a rear cover disposed on a rear side of the display, a first speaker disposed between the display and the rear cover, and a second speaker disposed between the display and the rear cover and positioned higher than the first speaker. The second speaker outputs audio according to operation of a piezoelectric element, and has a higher audio output band than the first speaker. This enables a user to feel as if the audio is being output from the display being viewed, which enhances the sound image localization effect and ensures a good viewing state in which an image or video and audio have a sense of unity.

Abstract: A method of manufacturing an inductor component includes preparing an insulating paste that is photosensitive and that includes a filler material composed of quartz, a glass material and a resin material, and a conductive paste, forming a first insulating layer by applying the insulating paste, and exposing the first insulating layer in a state where a first portion of the first insulating layer is shielded by a mask. The method further includes removing the first portion of the first insulating layer to form a groove at a position corresponding to the first portion, applying the conductive paste in the groove to form a coil conductor layer in the groove, and applying the insulating paste on the first insulating layer and the coil conductor layer to form a second insulating layer.

Abstract: A battery pack includes a battery stack, gas discharge valves, a housing and a metal plate. The battery stack includes plural battery cells arrayed in a thickness direction. The gas discharge valves are provided at top walls of the battery cells and discharge gas that is produced inside the battery cells. The housing is fabricated of resin and accommodates the battery stack in a hermetically sealed state. The metal plate is disposed inside the housing and opposes the gas discharge valves in a vertical direction.

Abstract: A battery stack including: plural battery cells that have been waterproofed, that are arrayed along a horizontal direction, and that each has a length direction running in a direction orthogonal to an array direction of the battery cells; and plural resin frames that are respectively provided between mutually adjacent battery cells, that support both length direction end portions of the battery cells, and that form an opening that exposes lower faces of the battery cells.

Abstract: A laminated substrate includes: a first substrate; a second substrate having a through-hole; a third substrate; a first adhesive layer bonding a rear surface of the first substrate and a front surface of the second substrate; a second adhesive layer bonding a rear surface of the second substrate and a front surface of the third substrate; a first post penetrating through the first adhesive layer, electrically connecting the first substrate to the second substrate, and made of an alloy of a high melting point metal and a low melting point metal; a second post penetrating through the second adhesive layer, electrically connecting the second substrate to the third substrate, and made of an alloy of the high melting point metal and the low melting point metal; and an electronic component fixed to the front surface of the third substrate and disposed in the through-hole of the second substrate.

Abstract: A laminated substrate includes: a first substrate; a second substrate having a through-hole; a third substrate; a first adhesive layer bonding a rear surface of the first substrate and a front surface of the second substrate; a second adhesive layer bonding a rear surface of the second substrate and a front surface of the third substrate; a first post penetrating through the first adhesive layer, electrically connecting the first substrate to the second substrate, and made of an alloy of a high melting point metal and a low melting point metal; a second post penetrating through the second adhesive layer, electrically connecting the second substrate to the third substrate, and made of an alloy of the high melting point metal and the low melting point metal; and an electronic component fixed to the front surface of the third substrate and disposed in the through-hole of the second substrate.

Abstract: A bonding material disclosed in this specification contains high melting point metal particles, low melting point metal particles, and a thermosetting flux resin. A mass proportion of the high melting point metal particles with respect to a total mass of the high melting point metal particles and the low melting point metal particles is 55% to 75%.

Abstract: The present invention relates to a novel 3-aminobenzamide, compound represented by the following formula which effectively inhibits vanilloid receptor subtype 1 (VR1) activity (wherein, for example, R1 is a C1-6 alkyl group which may be substituted, R2 is a hydrogen atom, a C1-6 alkyl group or a C1-6 alkoxy group which may be substituted, R3 is a hydrogen atom or a C1-6 alkyl group, R4 is a C1-6 alkyl group, a C1-6 alkoxy group, or a halo C1-6 alkyl group, m is an integer of 1 to 5 and P is a carbon or hetero ring) or a pharmaceutically acceptable salt thereof. The pharmaceutical composition comprising as active ingredients the 3-aminobenzamide, compound or a pharmaceutically acceptable salt thereof is useful for treating diseases involved in VR1 activity such as pain, acute pain, chronic pain, neuropathicpain, rheumatoid arthritis pain, and neuralgia.

Abstract: A 3,4-dihydrobenzoxazine compound of the present invention is represented by the following formula [1] (wherein X is a nitrogen atom or CR3; R1 is a hydrogen atom or a halogen atom; R2 is a C1-6 alkoxy group which may be substituted with the same or different 1 to 5 substituents selected from a halogen atom and a hydroxyl group; and R3 is a halogen atom. However, R1 is a halogen atom when X is CR3). This compound is effective in treating diseases to which the vanilloid receptor subtype 1 (VR1) activity is involved, such as pain, etc.

Abstract: To provide a compound having an excellent inhibitory effect on vanilloid receptor subtype 1 (VR1) activity which is effective in treating diseases to which the vanilloid receptor subtype 1 (VR1) activity is involved, such as pain, acute pain, chronic pain, neuropathic pain, rheumatoid arthritis pain, neuralgia, etc. and a pharmaceutical composition containing the compound.

Abstract: A 3,4-dihydrobenzoxazine compound of the present invention is represented by the following formula [1] (wherein X is a nitrogen atom or CR3; R1 is a hydrogen atom or a halogen atom; R2 is a C1-6 alkoxy group which may be substituted with the same or different 1 to 5 substituents selected from a halogen atom and a hydroxyl group; and R3 is a halogen atom. However, R1 is a halogen atom when X is CR3). This compound is effective in treating diseases to which the vanilloid receptor subtype 1 (VR1) activity is involved, such as pain, etc.

Abstract: The present invention relates to a novel 3-aminobenzamide compound represented by the following formula which effectively inhibits vanilloid receptor subtype 1 (VR1) activity (wherein, for example, R1 is a C1-6 alkyl group which may be substituted, R2 is a hydrogen atom, a C1-6 alkyl group or a C1-6 alkoxy group which may be substituted, R3 is a hydrogen atom or a C1-6 alkyl group, R4 is a C1-6 alkyl group, a C1-6 alkoxy group, or a halo C1-6 alkyl group, m is an integer of 1 to 5 and P is a carbon or hetero ring) or a pharmaceutically acceptable salt thereof. The pharmaceutical composition comprising as active ingredients the 3-aminobenzamide compound or a pharmaceutically acceptable salt thereof is useful for treating diseases involved in VR1 activity such as pain, acute pain, chronic pain, neuropathic pain, rheumatoid arthritis pain, and neuralgia.

Abstract: A 3,4-dihydrobenzoxazine compound of the present invention is represented by the following formula [1] (wherein X is a nitrogen atom or CR3; R1 is a hydrogen atom or a halogen atom; R2 is a C1-6 alkoxy group which may be substituted with the same or different 1 to 5 substituents selected from a halogen atom and a hydroxyl group; and R3 is a halogen atom. However, R1 is a halogen atom when X is CR3). This compound is effective in treating diseases to which the vanilloid receptor subtype 1 (VR1) activity is involved, such as pain, etc.

Abstract: The present invention relates to a novel 3-aminobenzamide compound represented by the following formula which effectively inhibits vanilloid receptor subtype 1 (VR1) activity (wherein, for example, R1 is a C1-6 alkyl group which may be substituted, R2 is a hydrogen atom, a C1-6 alkyl group or a C1-6 alkoxy group which may be substituted, R3 is a hydrogen atom or a C1-6 alkyl group, R4 is a C1-6 alkyl group, a C1-6 alkoxy group, or a halo C1-6 alkyl group, m is an integer of 1 to 5 and P is a carbon or hetero ring) or a pharmaceutically acceptable salt thereof. The pharmaceutical composition comprising as active ingredients the 3-aminobenzamide compound or a pharmaceutically acceptable salt thereof is useful for treating diseases involved in VR1 activity such as pain, acute pain, chronic pain, neuropathic pain, rheumatoid arthritis pain, and neuralgia.

Abstract: To provide a compound having an excellent inhibitory effect on vanilloid receptor subtype 1 (VR1) activity which is effective in treating diseases to which the vanilloid receptor subtype 1 (VR1) activity is involved, such as pain, acute pain, chronic pain, neuropathic pain, rheumatoid arthritis pain, neuralgia, etc. and a pharmaceutical composition containing the compound.

Abstract: A three-dimensional display comprising a flat light source, a vertical striped filter having slits transmitting light from the light source and barriers screening the light from the light source alternately formed therein for partially transmitting the light from the light source, and an LCD panel arranged on the light emission side of the vertical striped filter and having left eye pixels and right eye pixels alternately formed therein, light passing through the left eye pixels in the LCD panel and light passing through the right eye pixels being emitted toward a observer in a separated state.

Abstract: The 2-D/3-D compatible type image display according to the present invention is constructed by arranging a liquid crystal panel which is a display panel, a dispersed type liquid crystal panel which is a diffusing effect on/off panel, a light separating means, a backlight which is a plane light source, so as to be nearer to an observer in this order. It is possible by processing the image signal supplied to the liquid crystal panel to form a first group of pixels lined in longitudinal direction of a picture and a second group of pixels lined in the same direction of the picture alternately formed in horizontal direction, and to make the first group of pixels and the second group of pixels have different observing points respectively as left eye pixels and right eye pixels (when 3-D images are displayed), or to make the first group of pixels and the second group of pixels have the same observing points with each other (when 2-D images are displayed).

Abstract: The present invention is directed to a three-dimensional display panel capable of viewing a three-dimensional image without using special glasses. The three-dimensional display panel comprises an image display panel having a column of right eye pixels arranged with predetermined spacing in the longitudinal direction on a screen and a column of left eye pixels arranged with predetermined spacing in the longitudinal direction on the screen and so adapted that the column of right eye pixels and the column of left eye pixels are arranged alternately in close proximity to each other in the horizontal direction on the screen and are shifted from each other in the longitudinal direction on the screen to ensure a region where means for switching the respective pixels is formed, and image separating means for separating light from the right eye pixels and light from the left eye pixels to be respectively incident on the right eye and the left eye of a viewer.

Abstract: A flat display includes a closed vessel having a front panel (optically transparent) and a back panel, apparatus for emitting electrons by field emission positioned on the back panel, an anode having an anode electrode and at least a phosphor layer positioned on the front panel, and a spacer for defining a distance between the front panel and the back panel. The spacer has an upper cross-section adjacent to the front panel and a lower cross-section adjacent to the back panel. The lower cross-section is larger than the upper cross-section.